Skip to main content
Hualan Biological Engineering Inc. logo

Hualan Biological Engineering Inc. — Investor Relations & Filings

Ticker · 002007 ISIN · CNE000001JN8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2025-10-29 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002007

About Hualan Biological Engineering Inc.

https://www.hualanbio.com

Hualan Biological Engineering Inc. is a biopharmaceutical enterprise specializing in the research, development, production, and commercialization of blood products and vaccines. The company’s portfolio is divided into two primary segments: plasma-derived therapeutics and viral vaccines. Key blood products include human albumin, intravenous immunoglobulin (IVIG), human coagulation factor VIII, and prothrombin complex. In the vaccine sector, the company produces seasonal influenza vaccines, including quadrivalent formulations, as well as hepatitis B and rabies vaccines. Hualan Biological Engineering operates advanced manufacturing facilities and plasma collection centers, focusing on high-quality standards and technological innovation in recombinant protein drugs and monoclonal antibodies to address critical medical needs in immunology, hematology, and infectious disease prevention.

Recent filings

Filing Released Lang Actions
独立董事提名人声明
Board/Management Information Classification · 95% confidence The document is a public statement from the board of directors nominating an independent director candidate for the company's board. It contains detailed declarations about the nominee's qualifications, compliance with regulatory requirements, and independence criteria. There are no financial statements, earnings data, or report attachments. The document is a formal nomination announcement related to board/management changes rather than a financial report or regulatory filing. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and focused solely on the nomination statement, confirming it is not a full report or announcement of a report publication.
2025-10-29 Chinese
关于第九届董事会第三次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the company's ninth board of directors' third meeting. It details changes in board members, appointment of senior management, approval of a quarterly report, and other board decisions. It does not contain the full quarterly report itself but rather the board's approval and related decisions. The document is relatively short (2547 characters) and serves as a formal disclosure of board meeting outcomes. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2025-10-29 Chinese
独立董事候选人声明（张志谦）
Board/Management Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate for a company's board. It contains detailed affirmations about the candidate's qualifications, compliance with regulatory requirements, and independence criteria. There are no financial statements, earnings data, or report summaries. The document is not an announcement of a report publication but a formal statement related to board/management information, specifically about a director candidate's qualifications and commitments. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is 2787 characters, which is consistent with a detailed declaration rather than a full report.
2025-10-29 Chinese
关于独立董事辞职暨补选第九届董事会独立董事并调整董事会专门委员会委员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of an independent director and the subsequent election and appointment of a new independent director to the company's board. It also details adjustments to the board's specialized committees. The content focuses on board/management changes and does not contain financial data, earnings, or regulatory filings related to financial performance. The document is a formal announcement of changes in the company's board of directors and committee memberships, fitting the category of Board/Management Information (MANG). The document length is short and specific to management changes, not a full report or regulatory filing.
2025-10-29 Chinese
关于董事会秘书辞职暨聘任董事会秘书的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the current board secretary and the appointment of a new board secretary. It details the reasons for resignation, the qualifications of the new appointee, and compliance with regulatory requirements. There is no financial data, no report attached or referenced as being published, and no mention of financial results or corporate governance rules beyond the appointment. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2025-10-29 Chinese
关于财务总监辞职暨聘任财务总监的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the company's financial director and the appointment of a new financial director. It includes details about the outgoing and incoming financial directors, their qualifications, and compliance with relevant regulations. There is no financial data, report, or presentation included. This type of document fits the category of Board/Management Information (MANG), as it concerns changes in senior management positions.
2025-10-29 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.